Get our guide to planning and executing an M&A communications strategy. Download Now

Westicke Partners

Close

Kymera Therapeutics, Inc.

$200 Million Initial Public Offering

Case Study: Kymera Therapeutics, Inc.

ICR Westwicke began working with biopharmaceutical company Kymera Therapeutics in April 2020, providing strategic advice for the company’s IPO, throughout the underwriter selection process, S-1 drafting process, and four-day virtual roadshow. In August 2020, Kymera priced its upsized IPO at $20 per share.

Download the case study to learn how ICR Westwicke’s strategic advice led to a successful IPO, with shares closing up 66.3%.

12 Elements Your Investor Relations Website Must Include

Your company’s website is an opportunity to make a memorable first impression. Download our checklist, “12 Elements Your Investor Relations Website Must Include.”

 

Our Locations